Stay updated on Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial

Sign up to get notified when there's something new on the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new site revision entry v3.4.3 was added and v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-11T12:47:48.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A minor site revision (v3.4.2) was added; the non-critical funding-status notice and a prior revision notice (v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T02:43:55.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added, warning that information may not be up to date and that transactions may not be processed, with a link to opm.gov. The page revision label was updated to v3.4.1 (removing v3.4.0).
    Difference
    0.3%
    Check dated 2026-02-03T23:53:22.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Show glossary added; QC-related 'Last Update Submitted that Met QC Criteria' field added; No FEAR Act Data disclosure added; page revision updated to v3.4.0. Previously shown items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and revision v3.3.4 were removed.
    Difference
    0.1%
    Check dated 2026-01-27T22:49:58.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The page's Locations section was reorganized to enumerate site locations by state (Arizona, California, Colorado, Florida, Georgia, Illinois, Kentucky, Michigan, Mississippi, Missouri, Nebraska, New Mexico, North Carolina, Pennsylvania, Tennessee, Texas, Utah, Virginia, Washington) and a new Revision: v3.3.3 tag appears; individual state-location entries were removed, and the HHS Vulnerability Disclosure link was deleted.
    Difference
    1%
    Check dated 2025-12-23T00:34:52.000Z thumbnail image
  8. Check
    106 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2; it appears to be a minor site version update with no changes to the study details or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T11:43:15.000Z thumbnail image

Stay in the know with updates to Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page.